SCHEMBL4629191

SCHEMBL4629191

O=S(=O)(c1ccccc1CCCCOCCCCCCNCC(O)c1ccc(O)c(CO)n1)C1CCCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 19/20 0.57
ADRB1 P08588 19/20 0.57
ADRB3 P13945 19/20 0.57
CYP3A4 P08684 3/20 0.53
HTR1A P08908 3/20 0.53
CYP2D6 P10635 3/20 0.53
HTR1B P28222 3/20 0.53
KDM4E B2RXH2 1/20 0.45
CHRM5 P08912 1/20 0.45
DRD2 P14416 1/20 0.45
ADRA2B P18089 1/20 0.45
DRD4 P21917 1/20 0.45
SLC6A2 P23975 1/20 0.45
FPR3 P25089 1/20 0.45
ADRA1D P25100 1/20 0.45
HTR1D P28221 1/20 0.45
HTR2A P28223 1/20 0.45
HTR2C P28335 1/20 0.45
SLC6A4 P31645 1/20 0.45
GPR183 P32249 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4628260 0.84 ADRB2 (0.73) ADRB2ADRB1ADRB3CYP3A4HTR1A
SCHEMBL668163 0.84 ADRB2 (0.81) ADRB2ADRB1ADRB3CYP3A4HTR1A
SCHEMBL939190 0.84 ADRB2 (0.81) ADRB2ADRB1ADRB3CYP3A4HTR1A
Acetic Acid SCHEMBL4629147 0.81 ADRB2 (0.74) ADRB2ADRB1ADRB3CYP3A4HTR1A
SCHEMBL4629384 0.78 ADRB2 (0.63) ADRB2ADRB1ADRB3CYP3A4HTR1A
SCHEMBL10760810 0.78 ADRB2 (0.62) ADRB2ADRB1ADRB3CYP3A4HTR1A
SCHEMBL5126858 0.76 ADRB2 (0.71) ADRB2ADRB1ADRB3CYP3A4HTR1A
SCHEMBL10762117 0.75 ADRB2 (0.55) ADRB2ADRB1ADRB3CYP3A4HTR1A
SCHEMBL10763007 0.75 ADRB2 (0.52) ADRB2ADRB1ADRB3CYP3A4HTR1A
SCHEMBL5118990 0.74 ADRB2 (0.70) ADRB2ADRB1ADRB3CYP3A4HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1556342-B1 PHENETHANOLAMINE DERIVATIVE FOR THE TREATMENT OF RESPIRATORY DISEASES GLAXO GROUP LTD (GB) 2008-03-26 EP claimed